Caspase-3 protects stressed organs against cell death

Molecular and Cellular Biology

Volumn 32, Issue 22, 2012, Pages 4523-4533

  Khalil, Hadi ^a   Peltzer, Nieves ^a   Walicki, Joël ^a   Yang, Jiang Yan ^a   Dubuis, Gilles ^a   Gardiol, Noémie ^b   Held, Werner ^b   Bigliardi, Paul ^c,d   Marsland, Benjamin ^c   Liaudet, Lucas ^c   Widmann, Christian ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CASPASE 3; CASPASE INHIBITOR; PROTEIN KINASE B; PROTEIN P120; PROTEIN RASGAP; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL FATE; CELL PROTECTION; CELL SURVIVAL; CHEMICAL STRESS; COLITIS; CONTROLLED STUDY; DETERIORATION; EMBRYO; ENVIRONMENTAL STRESS; ENZYME ACTIVATION; KNOCKOUT MOUSE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SUNBURN;

ANIMALS; BASE SEQUENCE; CARDIOMYOPATHIES; CASPASE 3; CELL DEATH; COLITIS; DEXTRAN SULFATE; DOXORUBICIN; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HEMODYNAMICS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTATION; P120 GTPASE ACTIVATING PROTEIN; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; SUNBURN; ULTRAVIOLET RAYS;

MUS;

EID: 84868698549     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00774-12     Document Type: Article

References (51)

1. Abraham MC, Shaham S. 2004. Death without caspases, caspases without death. Trends Cell Biol. 14:184-193.
2. Alam A, Cohen LY, Aouad S, Sekaly RP. 1999. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190:1879-1890.
3. Bonnet MC, et al. 2011. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35:572-582.
4. Bulat N, et al. 2011. RasGAP-derived fragment N increases the resistance of beta cells towards apoptosis in NOD mice and delays the progression from mild to overt diabetes. PLoS One 6:e22609. doi:10.1371/ journal.pone.0022609.
5. Bulat N, Waeber G, Widmann C. 2009. LDLs stimulate p38 MAPKs and wound healing through SR-BI independently of Ras and PI3 kinase. J. Lipid Res. 50:81-89.
6. Burguillos MA, et al. 2011. Caspase signalling controls microglia activation and neurotoxicity. Nature 472:319-324.
7. Campbell DS, Holt CE. 2003. Apoptotic pathway and MAPKs differentially regulate chemotropic responses of retinal growth cones. Neuron 37:939-952.
8. Candi E, Schmidt R, Melino G. 2005. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6:328-340.
9. Carlile GW, Smith DH, Wiedmann M. 2004. Caspase-3 has a nonapoptotic function in erythroid maturation. Blood 103:4310-4316.
10. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL. 2003. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 8:345-352.
11. Cuvillier O, et al. 2001. Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ. 8:162-171.
12. Daniels F, Jr, Brophy D, Lobitz WC, Jr. 1961. Histochemical responses of human skin following ultraviolet irradiation. J. Invest. Dermatol. 37: 351-357.
13. Droin N, et al. 2008. A role for caspases in the differentiation of erythroid cells and macrophages. Biochimie 90:416-422.
14. Eymin B, et al. 1999. Caspase-induced proteolysis of the cyclindependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity. Oncogene 18:4839-4847.
15. Feinstein-Rotkopf Y, Arama E. 2009. Can't live without them, can live with them: roles of caspases during vital cellular processes. Apoptosis 14: 980-995.
16. Fernando P, Brunette S, Megeney LA. 2005. Neural stem cell differentiation is dependent upon endogenous caspase 3 activity. FASEB J. 19:1671-1673.
17. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. 2002. Caspase 3 activity is required for skeletal muscle differentiation. Proc. Natl. Acad. Sci. U. S. A. 99:11025-11030.
18. Fujita J, et al. 2008. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2:595-601.
19. Giaime E, et al. 2006. Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway. J. Biol. Chem. 281:11515-11522.
20. Holler N, et al. 2003. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol. Cell. Biol. 23:1428-1440.
21. Jianhui L, et al. 2010. Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. Am. J. Physiol. Heart Circ. Physiol. 299:H492-H501.
22. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190:1891-1896.
23. Kuranaga E, Miura M. 2007. Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol. 17:135-144.
24. Launay S, et al. 2005. Vital functions for lethal caspases. Oncogene 24: 5137-5148.
25. Leonard JR, Klocke BJ, D'Sa C, Flavell RA, Roth KA. 2002. Straindependent neurodevelopmental abnormalities in caspase-3-deficient mice. J. Neuropathol. Exp. Neurol. 61:673-677.
26. Li Z, et al. 2010. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141:859-871.
27. Liadis N, et al. 2005. Caspase-3-dependent β-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol. Cell. Biol. 25:3620-3629.
28. Luciano F, Herrant M, Jacquel A, Ricci JE, Auberger P. 2003. The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCRinduced cell death in B lymphoma acts as a negative regulator of apoptosis. FASEB J. 17:711-713.
29. Mansilla S, Priebe W, Portugal J. 2006. Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 5:53-60.
30. McLaughlin B, et al. 2003. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Natl. Acad. Sci. U. S. A. 100:715-720.
31. Michod D, Widmann C. 2007. TAT-RasGAP317-326 requires p53 and PUMAto sensitize tumor cells to genotoxins. Mol. Cancer Res. 5:497-507.
32. Miossec C, Dutilleul V, Fassy F, Diu-Hercend A. 1997. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272:13459-13462.
33. Miura M, et al. 2004. A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J. Clin. Invest. 114:1704-1713.
34. Mogi M, Togari A. 2003. Activation of caspases is required for osteoblastic differentiation. J. Biol. Chem. 278:47477-47482.
35. Newton K, Strasser A. 2003. Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev. 17:819-825.
36. Ohkawara T, et al. 2005. Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis. Clin. Exp. Immunol. 140:241-248.
37. Oomman S, Strahlendorf H, Dertien J, Strahlendorf J. 2006. Bergmann glia utilize active caspase-3 for differentiation. Brain Res. 1078:19-34.
38. Pacher P, et al. 2003. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107:896-904.
39. Pacher P, et al. 2004. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am. J. Physiol. Heart Circ. Physiol. 287:H2132-H2137.
40. Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. 2008. PKB and the mitochondria: AKTing on apoptosis. Cell. Signal. 20:21-30.
41. Peter ME. 2011. Programmed cell death: apoptosis meets necrosis. Nature 471:310-312.
42. Rincheval V, Renaud F, Lemaire C, Mignotte B, Vayssiere JL. 1999. Inhibition of Bcl-2-dependent cell survival by a caspase inhibitor: a possible new pathway for Bcl-2 to regulate cell death. FEBS Lett. 460:203-206.
43. Slee EA, Adrain C, Martin SJ. 2001. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276:7320-7326.
44. Sordet O, et al. 2002. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100:4446-4453.
45. Taylor RC, Cullen SP, Martin SJ. 2008. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9:231-241.
46. Woo M, et al. 2003. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat. Immunol. 4:1016-1022.
47. Yang J-Y, et al. 2004. Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions. Mol. Cell. Biol. 24:10425-10436.
48. Yang J-Y, Walicki J, Michod D, Dubuis G, Widmann C. 2005. Impaired Akt activity down-modulation, caspase-3 activation, and apoptosis in cells expressing a caspase-resistant mutant of RasGAP at position 157. Mol. Biol. Cell 16:3511-3520.
49. Yang J-Y, Widmann C. 2001. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol. Cell. Biol. 21:5346-5358.
50. Yang J-Y, Widmann C. 2002. The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/Akt-dependent manner that does not rely on NF B activation. J. Biol. Chem. 277:14641-14646.
51. Youn HJ, et al. 2005. Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment. Mol. Cell. Biochem. 270: 13-19.